pcvx: the income statement

MyFinsight

Vaxcyte, Inc. (PCVX)

For the quarter ending 2025-06-30, PCVX made $59,646K in revenue. -$166,573K in net income. Net profit margin of -279.27%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	194,179
General and administrative	32,040
Total operating expenses	226,219
Loss from operations	-226,219
Other income (expense)	28,573
Interest income	31,073
Total other income, net	59,646
Net loss	-166,573

Net loss per share, basic (in dollars per share)	-1.22
Net loss per share, diluted (in dollars per share)	-1.22
Weighted-average shares outstanding, basic (in shares)	136,033,746
Weighted-average shares outstanding, diluted (in shares)	136,033,746

Unit: Thousand (K) dollars (except for numbers of shares and EPS)